You just read:

DALCOR PHARMA LICENSES A LATE-STAGE INVESTIGATIONAL CARDIOVASCULAR DRUG FOLLOWING MAJOR DISCOVERY BY MONTREAL HEART INSTITUTE (MHI) SCIENTISTS

News provided by

Montreal Heart Institute

08 Jun, 2015, 15:01 BST